麦克森 2026年季度报告

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December31, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromtoCommission File Number: 1-13252 McKESSON CORPORATION(Exact name of registrant as specified in its charter) 94-3207296(I.R.S. EmployerIdentification No.) 6555 State Hwy 161,Irving, TX 75039(Address of principal executive offices, including zip code)(972) 446-4800(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and(2)has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuantto Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant wasrequired to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and“emerging growth company” in Rule 12b-2 of the Exchange Act. AcceleratedfilerSmallerreportingcompanyEmerging growth company Ifan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).Yes☐No☒ Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date 122,487,456shares of the issuer’s common stock were outstanding as of January30, 2026. McKESSON CORPORATION TABLE OF CONTENTS Item PART I—FINANCIAL INFORMATION 1Condensed Consolidated Financial StatementsCondensed Consolidated Statements of Operations for the three and nine months endedDecember 31, 2025 and 2024Condensed Consolidated Statements of Comprehensive Income for the three and nine months endedDecember 31, 2025 and2024Condensed Consolidated Balance Sheets as ofDecember 31, 2025 andMarch 31, 2025Condensed Consolidated Statements of Stockholders’ Deficit for the three and nine months endedDecember 31, 2025 and2024Condensed Consolidated Statements of Cash Flows for the nine months endedDecember 31, 2025 and 2024Financial NotesNote 1 - Significant Accounting PoliciesNote 2 - Business Acquisitions and DivestituresNote 3 - Restructuring, Impairment, and Related Charges, NetNote 4 - Income TaxesNote 5 - Redeemable Noncontrolling Interests and Noncontrolling InterestsNote 6 - Earnings Per Common ShareNote 7 - Goodwill and Intangible Assets, NetNote 8 - Debt and Financing ActivitiesNote 9 - Hedging ActivitiesNote 10 - Fair Value MeasurementsNote 11 - Commitments and Contingent LiabilitiesNote 12 - Stockholders’ DeficitNote 13 - Segments of Business2Management’s Discussion and Analysis of Financial Condition and Results of Operations3Quantitative and Qualitative Disclosures About Market Risk4Controls and ProceduresPART II—OTHER INFORMATION1Legal Proceedings1ARisk Factors2Unregistered Sales of Equity Securities and Use of Proceeds3Defaults Upon Senior Securities4Mine Safety Disclosures5Other Information6ExhibitsSignatures McKESSON CORPORATION PART I—FINANCIAL INFORMATION McKESSON CORPORATION McKESSON CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS(In millions, except per share amounts)(Unaudited) December 31,2025March 31, 2025 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND DEFICITCurrent liabilities McKESSON CORPORATION McKESSON CORPORATION FINANCIAL NOTES(UNAUDITED) 1.Significant Accounting Policies Nature of Operations: McKesson Corporation together with its subsidiaries (collectively, the “Company” or “McKesson”) is adiversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson partners with biopharmacompanies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to help makequality care more accessible and affordable. Commencing in the second quarter of fiscal 2026, the Company reports its financial results infour reportable segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions (“RxTS”), andMedical-Surgical Solutions. The Company’s Norwegian operations are include